E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/19/2009 in the Prospect News PIPE Daily.

New Issue: Encorium Group sells $1.58 million of shares through private placement

By Devika Patel

Knoxville, Tenn., Oct. 19 - Encorium Group, Inc. settled a $1.58 million private placement of stock on Oct. 16, according to an 8-K filed Monday with the Securities and Exchange Commission.

The company sold 3,937,500 common shares at $0.40 per share.

Proceeds will be used for working capital purposes.

Located in Wayne, Pa., Encorium develops and manages clinical trials and patient registries for pharmaceutical and biotechnology companies.

Issuer:Encorium Group, Inc.
Issue:Common stock
Amount:$1,575,000
Shares:3,937,500
Price:$0.40
Warrants:No
Settlement date:Oct. 16
Stock symbol:Nasdaq: ENCO
Stock price:$0.4399 at close Oct. 16
Market capitalization:$8.16 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.